RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2019

Jan 18, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2019-01-16

Reporting Person: Van der Ploeg Leonardus H.T. (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-16	Common Stock	S	200	$30.00	Disposed	42339	Direct

Footnotes

F1: On January 16, 2019, Mr. Van der Ploeg sold 200 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.